Big Gain For Rubius Therapeutics, Inc.
Tue, Dec 26, 2023 at 07:06 PM
Rubius Therapeutics, Inc. (RUBY:NASDAQ) jumped higher at $0.06, representing a gain of 175%. On Tue, Dec 26, 2023, RUBY:NASDAQ hit a New 2-Week High of $0.06. From Tue, Dec 12, 2023, the stock recorded 22.22% Up Days and 10.00% Green Days
About Rubius Therapeutics, Inc. (RUBY:NASDAQ)
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 222.58%
- ARB IOT Group Limited (ARBB:NASDAQ), 175.53%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 175%
- Baudax Bio, Inc. (BXRX:NASDAQ), 139.88%
- RayzeBio Inc. (RYZB:NASDAQ), 100.85%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 80.87%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 62.14%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 60.26%
- Sight Sciences Inc. (SGHT:NASDAQ), 46.7%